Tirzepatide is the proven, accessible, well-characterized option that delivers exceptional results for most people
Liver disease data from SYNERGY The SYNERGY MASLD trial could be the most commercially significant readout
Slow, attentive eating and regular sleep patterns align with GLP-1's circadian rhythm
This difference could affect the way the medications work for weight loss and diabetes management
Emailed about an older lot certificate and support sent the full PDF the same afternoon
If you were a betting person, youd probably bet that wed end up with nothing. Its very rare, frankly, that something goes this way and that frequently its a combination of luck, some intelligence, some foresight into doing the right experiments, Raufman said